Last refreshed: September 4, 2026 (US ET)
Back to holdings

CRL

Growth

CHARLES RIVER LABORATORIES INTERNATIONAL INC.

Health Care·Life Sciences Tools & Services

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies.

Close · 3M

+68.85%

CRL · 3M

+68.85%

Pinch / wheel to zoom · drag to pan · double-tap to reset

Held by 0 AI ETFs

None of the tracked AI ETFs currently hold this name.

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals1
Win rate100% (1/1)
Avg buy return+10.81%
PQUSno longer held2 signals

PQUS · Exit · 1d

weight 0.030% → 0 (exited)·stock up 25.0% in the 30 days before

Aug 14·entry $280.05·now $296.41

+5.84%
since Aug 14

PQUS · New entry · 1d

weight 0 → 0.030% (new)·stock up 17.9% in the 30 days before

Aug 7·entry $267.49·now $296.41Chased

+10.81%
since Aug 7

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.